A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia A Pl...
A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia
About this item
Full title
Author / Creator
Publisher
Tehran University of Medical Sciences
Journal title
Language
English
Formats
Publication information
Publisher
Tehran University of Medical Sciences
Subjects
More information
Scope and Contents
Contents
Selective estrogen receptor modulators (SERMs) such as raloxifene have already shown beneficial effects on negative, positive and general psychopathology symptoms in postmenopausal women with schizophrenia. The purpose of the present investigation was to assess the efficacy of raloxifene as an adjuvant agent in the treatment of men with chronic sch...
Alternative Titles
Full title
A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_560812c8897d4d2d91007eafb587c644
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_560812c8897d4d2d91007eafb587c644
Other Identifiers
ISSN
0044-6025
E-ISSN
1735-9694
